ArticleBMC women's health2009
Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study.
Article in BMC women's health, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- A review of current practices to increase Chlamydia screening in the community--a consumer-centred social marketing perspective.Health expectations : an international journal of public participation in health care and health policy · 2016Pooled it
- Home-based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes.BMC public health · 2013Pooled it
- Review of services provided by pharmacies that promote healthy living.International journal of clinical pharmacy · 2012Pooled it
- Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa.PloS one · 2024Article
- Sexual and reproductive health services provided by community pharmacists: a scoping review.BMJ open · 2021Article
- Pharmacist-led screening in sexually transmitted infections: current perspectives.Integrated pharmacy research & practice · 2018Review
- Exploring pharmacy and home-based sexually transmissible infection testing.Sexual health · 2015Article
- STI testing in emergency contraceptive consultations.The British journal of general practice : the journal of the Royal College of General Practitioners · 2015Article
- To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia.BMJ open · 2013Article
- Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae.Expert review of anti-infective therapy · 2011Review
- Are pharmacists prepared to be sexual/reproductive health educators?American journal of pharmaceutical education · 2010Article
- Home-based chlamydia testing of young people attending a music festival--who will pee and post?BMC public health · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMore women are requesting Emergency Hormonal Contraception (EHC) at pharmacies where screening for Chlamydia trachomatis is not routinely offered. The objective of this study was to assess the uptake of free postal chlamydia screening by women under 25 years who requested EHC at pharmacies in Manchester, UK.
methodsSix Primary Care Trusts (PCTs) that had contracted with pharmacies to provide free EHC, requested the largest EHC providers (> or = 40 doses annually) to also offer these clients a coded chlamydia home testing kit. Pharmacies kept records of the ages and numbers of women who accepted or refused chlamydia kits. Women sent urine samples directly to the laboratory for testing and positive cases were notified. Audit data on EHC coverage was obtained from PCTs to assess the proportion of clients eligible for screening and to verify the uptake rate.
results33 pharmacies participated. Audit data for 131 pharmacy months indicated that only 24.8% (675/2718) of women provided EHC were also offered chlamydia screening. Based on tracking forms provided by pharmacies for the whole of the study, 1348/2904 EHC clients (46.4%) who had been offered screening accepted a screening kit. 264 (17.6%) of those who accepted a kit returned a sample, of whom 24 (9.1%) were chlamydia-positive. There was an increase in chlamydia positivity with age (OR: 1.2 per year; 1.04 to 1.44; p = 0.015).
conclusionChlamydia screening for EHC pharmacy clients is warranted but failure of pharmacists to target all EHC clients represented a missed opportunity for treating a well defined high-risk group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.